Deep ulcers are associated with increased C-reactive protein in active ulcerative colitis

Dig Liver Dis. 2023 Sep;55(9):1194-1200. doi: 10.1016/j.dld.2023.05.004. Epub 2023 May 25.

Abstract

Background: Increased C-reactive protein (CRP) is used to diagnose and predict response to treatment in acute severe ulcerative colitis (UC).

Aims: To investigate the connection between CRP elevation and deep ulcers in UC.

Methods: Patients with active UC were enrolled in a multicenter prospective cohort and a retrospective cohort of consecutive patients undergoing colectomy from 2012 to 2019.

Results: Forty-one (9 (22%) with deep ulcers) patients were included in the prospective cohort: 4/5 (80%) patients with CRP > 100 mg/L, 2/10 (20%) patients with CRP between 30 and 100 mg/L and 3/26 (12%) patients with CRP < 30 mg/L had deep ulcers (p = 0.006). In the retrospective cohort [46 patients (31 (67%) with deep ulcers)], 14/14 (100%) patients with CRP > 100 mg/L, 11/17 (65%) patients with CRP between 30 and 100 mg/l and 6/15 (40%) patients with CRP < 30 mg/L had deep ulcers (p = 0.001). Positive predictive value of CRP > 100 mg/l for presence of deep ulcers was 80% and 100% in both cohorts, respectively.

Conclusions: CRP elevation is a robust surrogate marker for presence of deep ulcers in UC. Elevated CRP or presence of deep ulcers could influence the choice of medical therapy in acute severe UC.

Keywords: Acute severe ulcerative colitis; Albumin; C-reactive protein; Deep ulcers; Endoscopy; Severe endoscopic lesions; UCEIS; Ulcerative colitis.

Publication types

  • Multicenter Study

MeSH terms

  • Biomarkers
  • C-Reactive Protein / metabolism
  • Colitis, Ulcerative* / complications
  • Colitis, Ulcerative* / diagnosis
  • Colitis, Ulcerative* / surgery
  • Humans
  • Prospective Studies
  • Retrospective Studies
  • Severity of Illness Index
  • Ulcer

Substances

  • Biomarkers
  • C-Reactive Protein
  • CRP protein, human